|
Market Closed -
Nasdaq
01:30:00 22/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.5622 USD | -8.75% |
|
+29.48% | -90.81% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
ce3bed6890931bff45a0de.lQ6wUDXM0h7ffWR9T6NdC27j60d_Sr8oPBCVErmfajg.wFr_BFmjuk-KRAAtJPssfwunoxQOGvZlRUbXZv71Jk7-OsgAXZnnfPJMXA~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +1,978.14% | |||||
| +30.22% | |||||
| +28.19% | |||||
| +11.71% | |||||
| +9.41% | |||||
| +12.94% | |||||
| +32.56% | |||||
| +35.55% | |||||
| +21.74% | |||||
| +5.95% | |||||
| Average | +216.64% | |||||
| Weighted average by Cap. | +21.78% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.5622USD
Average target price
11.68USD
Spread / Average Target
+1,978.14%
High Price Target
15.05USD
Spread / Highest target
+2,576.98%
Low Price Target
8.000USD
Spread / Lowest Target
+1,322.98%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
